Back to Search
ILYA GOLDENBERG, MD
MD
Hospitalist Physician
NPI: 1619976669IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
35-081219(OH)
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
35-081219(OH)
Education
OTHER
Class of 1996
Research & Publications (20)
Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators.
PMID 19324304·Heart Rhythm·2009
4-observational
Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial.
PMID 19273782·Arch Intern Med·2009
2-rct
Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.
PMID 19490272·J Cardiovasc Electrophysiol·2009
4-observational
Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
PMID 19576345·Am J Cardiol·2009
8-other
Reversible acute kidney injury following contrast exposure and the risk of long-term mortality.
PMID 18753738·Am J Nephrol·2009
8-other
Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
PMID 19101227·Am J Cardiol·2009
4-observational
Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
PMID 19017351·J Cardiovasc Electrophysiol·2009
8-other
Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists.
PMID 18805113·Am J Cardiol·2008
8-other
Comparison of outcomes in high-risk patients>70 years of age with aortic valvuloplasty and percutaneous coronary intervention versus aortic valvuloplasty alone.
PMID 18435963·Am J Cardiol·2008
4-observational
Implantable cardioverter defibrillator efficacy and chronic kidney disease: competing risks of arrhythmic and nonarrhythmic mortality.
PMID 18775038·J Cardiovasc Electrophysiol·2008
8-other
Secondary prevention with bezafibrate therapy for the treatment of dyslipidemia: an extended follow-up of the BIP trial.
PMID 18222357·J Am Coll Cardiol·2008
2-rct
Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
PMID 18206738·J Am Coll Cardiol·2008
2-rct
Update on the use of fibrates: focus on bezafibrate.
PMID 18629356·Vasc Health Risk Manag·2008
6-review
Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
PMID 18565233·Cardiovasc Diabetol·2008
8-other
Phenotypic variability in Caucasian and Japanese patients with matched LQT1 mutations.
PMID 18713323·Ann Noninvasive Electrocardiol·2008
4-observational
Cumulative burden of atherosclerotic risk genotypes and the age at onset of a first myocardial infarction: a case-only carriership approach.
PMID 18713330·Ann Noninvasive Electrocardiol·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2000 TAMARACK RD
NEWARK, OH 43055 - Phone
- (614) 297-1158
Quick Facts
- NPI
- 1619976669
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile